Abadi Nusantara Hijau Investama Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Abadi Nusantara Hijau Investama Tbk. trades at Rp560 (market cap 17.39T, 237.28M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Abadi Nusantara Hijau Investama Tbk. is far larger — about 166.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PACK | SCPI | |
|---|---|---|
Market Cap | 17.39T | 104.4B |
Volume | 237.28M | — |
Lot | 2.37M | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Solusi Kemasan Digital Tbk (the Company) was established based on Notarial Deed No. 10 dated November 8, 2019 of Laurens Gunawan, S.H., M.Kn., notary in Tangerang. The Company started itscommercial operations in December 6, 2019.
Read more on PACK →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →